New results in animals highlight a major safety concern regarding a class of magnetic resonance imaging (MRI) contrast agents used in millions of patients each year. The study adds to concerns that repeated use of specific "linear"-type gadolinium-based contrast agents (GBCAs) lead to deposits of the heavy-metal element gadolinium in the brain.
from Today's Healthcare News -- ScienceDaily http://ift.tt/1CxzIWS
No comments:
Post a Comment